A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years

Allergan

Status: Completed

Conditions: Glaucoma, Open-Angle

Treatments: Other: Standard of Care

Study type: Observational

Funder types: Industry

Identifiers

NCT01629407

MAF/AGN/OPH/GLA/015

Details and patient eligibility

About

This is an epidemiological, non-interventional, prospective study to collect data on glaucoma progression in a routine setting. Patients may receive treatment at the discretion of their physician per local standard of care.

Enrollment: 315 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Glaucoma in one or both eyes

Exclusion criteria

• Participation in a glaucoma therapeutic clinical trial

Trial design

315 participants in 1 patient group

Glaucoma

Description:

Patients with glaucoma

Treatment:

Other: Standard of Care